Home > Papers

 
 
Increased expression of tyrosine phosphatase SHP-2(PTPN11) in Helicobacter pylori-infected gastric cancer
JIANG Jing 1 #,KONG Fei 2,JING Meishan 3,CAO Xueyuan 4 *
1.Division of Clinical Epidemiology, Jilin University First Hospital, ChangChun 130021
2.Division of Clinical Epidemiology, Jilin University First Hospital, Changchun 130021, Jilin Province, China
3.Division of Pathology, Jilin University First Hospital, Changchun 130021, Jilin Province,China
4.Department of Gastric and Colorectal Surgery, Jilin University First Hospital, Changchun 130021, Jilin Province, China
*Correspondence author
#Submitted by
Subject:
Funding: Specialized Research Fund for the Doctoral Program of Higher Education(No.No. 20090061120086), National Natural Science Foundation of China (No.No.81072369 ), Natural Science Foundation of China Jilin Province(No.No.200905131)
Opened online:27 December 2012
Accepted by: none
Citation: JIANG Jing,KONG Fei,JING Meishan.Increased expression of tyrosine phosphatase SHP-2(PTPN11) in Helicobacter pylori-infected gastric cancer[OL]. [27 December 2012] http://en.paper.edu.cn/en_releasepaper/content/4505643
 
 
AIM To explore the alteration of Tyrosine phosphatase SHP-2 (PTPN11) protein expression in gastric cancer and to assess its prognostic values. METHODS Three hundred and five consecutive cases of gastric cancer were enrolled in the study. SHP-2 expression was carried out in 305 gastric cancer specimen, of which 83 had paired adjacent normal gastric mucus samples using a tissue microarray immunohistochemistry method. Correlations were analyzed between expression levels of SHP-2 protein and tumor parameters or clinical outcomes. Serum anti- Helicobacter pylori (H.pylori) IgG was detected by enzyme-linked immunosorbent assay (ELISA) method. Cox proportional hazards model was used to evaluate prognostic values by compassion of the expression levels of SHP-2 and disease-specific survivals in patients. RESULTS SHP-2 staining was mainly found diffuse in the cytoplasm and the weak staining was also observed in the nucleus in gastric mucosa cells. 32.5% of normal epithelial specimen and 62.6% of gastric cancer specimen were identified to stain with SHP-2 antibody positively (P < 0.001). Though SHP-2 staining intensities were observed stronger in the H.pylori (+) group compared to the H.pylori (-) group, however, no statistically significant difference was found in the expression levels of SHP-2 between H.pylori (+) and H.pylori (-) gastric cancer (P=0.40). The SHP-2 expression in gastric cancer was not significantly associated with cancer stages, lymph node metastases, and distant metastasis of the tumors (P=0.34, P=0.17, P=0.52). Multivariate analysis demonstrated no correlation between SHP-2 expression and disease free survival (P=0.86). CONCLUSION Increased expression of SHP-2 protein in gastric cancer specimen suggesting the aberrant upregulation of SHP-2 protein might play an important role in the gastric carcinogenesis.
Keywords:Gastric cancer; SH2-containing protein tyrosine phosphatase 2; Expression; H. pylori
 
 
 

For this paper

  • PDF (0B)
  • ● Revision 0   
  • ● Print this paper
  • ● Recommend this paper to a friend
  • ● Add to my favorite list

    Saved Papers

    Please enter a name for this paper to be shown in your personalized Saved Papers list

Tags

Add yours

Related Papers

Statistics

PDF Downloaded 259
Bookmarked 0
Recommend 5
Comments Array
Submit your papers